What does effect of equity units (in shares) mean?

Quantifies the additional common shares that would be issued if outstanding equity-linked instruments or units were converted into equity. This figure is essential for calculating fully diluted earnings per share and understanding potential shareholder dilution.

BioCryst Pharmaceuticals BCRX Effect of equity units (in shares)

Effect of equity units (in shares) at other companies

BioCryst PharmaceuticalsBCRX

0-100%

Carnival CorporationCCL

8M—

NiSourceNI

0—

BeldenBDC

581K-14.3%

ePlusPLUS

137K-16.0%

First BanCorpFBP

839K+2.9%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's effect of equity units (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's effect of equity units (in shares)?: BioCryst Pharmaceuticals (BCRX) reported effect of equity units (in shares) of 0 in Q1 2026.
How has BioCryst Pharmaceuticals's effect of equity units (in shares) changed year-over-year?: BioCryst Pharmaceuticals's effect of equity units (in shares) decreased by 100.0% year-over-year, from 2M to 0.
What does effect of equity units (in shares) mean?: Quantifies the additional common shares that would be issued if outstanding equity-linked instruments or units were converted into equity. This figure is essential for calculating fully diluted earnings per share and understanding potential shareholder dilution.